Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 4/2012

01.12.2012 | case report

Transient elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism

verfasst von: Heike Seifert, Sacha Rothschild

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

We present the case of a 58-year-old woman referred to our outpatient department because of the elevated serum levels of carcinoembryonic antigen (CEA) during routine follow-up 6 years after the diagnosis and therapy of localized rectal cancer. Radiographic and endoscopic examinations did not reveal tumor recurrence or metastases. An asymptomatic hypothyroidism was diagnosed by routine serum marker analysis. Serum CEA level decreased upon adequate substitution of the hypothyroidism. This case illustrates the influence of thyroid function on Serum CEA levels and confirms hypothyroidism as a rare but relevant differential diagnosis of elevated serum CEA levels.
Literatur
1.
Zurück zum Zitat Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43(9):1348–60.PubMedCrossRef Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43(9):1348–60.PubMedCrossRef
2.
Zurück zum Zitat Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47(4):624–30.PubMed Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47(4):624–30.PubMed
3.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.PubMedCrossRef
5.
Zurück zum Zitat Tulloch BR. Lipid changes in thyroid disease: the effect of thyroxine and analogues. Proc R Soc Med. 1974;67(7):670–1.PubMed Tulloch BR. Lipid changes in thyroid disease: the effect of thyroxine and analogues. Proc R Soc Med. 1974;67(7):670–1.PubMed
6.
Zurück zum Zitat Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg. 1994;219(2):174–82.PubMedCrossRef Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg. 1994;219(2):174–82.PubMedCrossRef
7.
Zurück zum Zitat Rosen M, Chan L, Beart RW, Jr., Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41(9):1116–26.PubMedCrossRef Rosen M, Chan L, Beart RW, Jr., Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum. 1998;41(9):1116–26.PubMedCrossRef
8.
Zurück zum Zitat Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813.PubMedCrossRef Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813.PubMedCrossRef
9.
Zurück zum Zitat Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.PubMedCrossRef Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.PubMedCrossRef
10.
Zurück zum Zitat Shuster J, Silverman M, Gold P. Metabolism of human carcinoembryonic antigen in xenogeneic animals. Cancer Res. 1973;33(1):65–8.PubMed Shuster J, Silverman M, Gold P. Metabolism of human carcinoembryonic antigen in xenogeneic animals. Cancer Res. 1973;33(1):65–8.PubMed
11.
Zurück zum Zitat Loewenstein MS, Zamcheck N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer. 1978;42 Suppl 3:1412–8.CrossRef Loewenstein MS, Zamcheck N. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer. 1978;42 Suppl 3:1412–8.CrossRef
12.
Zurück zum Zitat Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol. 1991;7(3):162–6.PubMedCrossRef Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol. 1991;7(3):162–6.PubMedCrossRef
13.
Zurück zum Zitat Hashimoto T, Matsubara F. Changes in the tumor marker concentration in female patients with hyper-, eu-, and hypothyroidism. Endocrinol Jpn. 1989;36(6):873–9.PubMedCrossRef Hashimoto T, Matsubara F. Changes in the tumor marker concentration in female patients with hyper-, eu-, and hypothyroidism. Endocrinol Jpn. 1989;36(6):873–9.PubMedCrossRef
14.
Zurück zum Zitat Amino N, Kuro R, Yabu Y, Takai SI, Kawashima M, Morimoto S, et al. Elevated levels of circulating carcinoembryonic antigen in hypothyroidism. J Clin Endocrinol Metab. 1981;52(3):457–62.PubMedCrossRef Amino N, Kuro R, Yabu Y, Takai SI, Kawashima M, Morimoto S, et al. Elevated levels of circulating carcinoembryonic antigen in hypothyroidism. J Clin Endocrinol Metab. 1981;52(3):457–62.PubMedCrossRef
15.
Zurück zum Zitat Kawashima M, Amino N, Kuro R, Yabu Y, Ichihara K, Miyai K, et al. Increase of serum carcinoembryonic antigen (CEA) in hypothyroidism. Rinsho Byori. 1982;30(8):903–6.PubMed Kawashima M, Amino N, Kuro R, Yabu Y, Ichihara K, Miyai K, et al. Increase of serum carcinoembryonic antigen (CEA) in hypothyroidism. Rinsho Byori. 1982;30(8):903–6.PubMed
16.
Zurück zum Zitat Depczynski B, Ward R, Eisman J. The association between myxedematous ascites and extreme elevation of serum tumor markers. J Clin Endocrinol Metab. 1996;81(11):4175.PubMedCrossRef Depczynski B, Ward R, Eisman J. The association between myxedematous ascites and extreme elevation of serum tumor markers. J Clin Endocrinol Metab. 1996;81(11):4175.PubMedCrossRef
17.
Zurück zum Zitat van Mil AH, Beijer C, Jonkers GJ. High levels of carcinoembryonic antigen in a woman with hypothyroidism. Ned Tijdschr Geneeskd. 2001;145(22):1071–4 (Hoge concentratie van carcino-embryonaal antigeen bij een vrouw met hypothyreoidie).PubMed van Mil AH, Beijer C, Jonkers GJ. High levels of carcinoembryonic antigen in a woman with hypothyroidism. Ned Tijdschr Geneeskd. 2001;145(22):1071–4 (Hoge concentratie van carcino-embryonaal antigeen bij een vrouw met hypothyreoidie).PubMed
18.
19.
Zurück zum Zitat Krishnan ST, Philipose Z, Rayman G. Lesson of the week: Hypothyroidism mimicking intra-abdominal malignancy. BMJ. 2002;325(7370):946–7.PubMedCrossRef Krishnan ST, Philipose Z, Rayman G. Lesson of the week: Hypothyroidism mimicking intra-abdominal malignancy. BMJ. 2002;325(7370):946–7.PubMedCrossRef
20.
Zurück zum Zitat Bertola G, Balza G, Oriani A, Morganti D, Sironi C, Bonizzato S. Elevated concentration of serum carcinoembryonic antigen in hypothyroidism. Recenti Prog Med. 2004;95(4):204–6 (Elevate concentrazioni sieriche di antigene carcinoembrionario in corso di ipotiroidismo).PubMed Bertola G, Balza G, Oriani A, Morganti D, Sironi C, Bonizzato S. Elevated concentration of serum carcinoembryonic antigen in hypothyroidism. Recenti Prog Med. 2004;95(4):204–6 (Elevate concentrazioni sieriche di antigene carcinoembrionario in corso di ipotiroidismo).PubMed
21.
Zurück zum Zitat Aguiar-Bujanda D, Bohn-Sarmiento U, Aguiar-Morales J. False elevation of serum CA 15–3 levels in patients under follow-up for breast cancer. Breast J. 2004;10(4):375–6.PubMedCrossRef Aguiar-Bujanda D, Bohn-Sarmiento U, Aguiar-Morales J. False elevation of serum CA 15–3 levels in patients under follow-up for breast cancer. Breast J. 2004;10(4):375–6.PubMedCrossRef
22.
Zurück zum Zitat Rothschild S, Frei J. CEA-Erhöhung bei Hypothyreose. Schweiz Med Forum. 2005;5:783–4. Rothschild S, Frei J. CEA-Erhöhung bei Hypothyreose. Schweiz Med Forum. 2005;5:783–4.
23.
Zurück zum Zitat Duarte DR, Chang CV, Minicucci MF, Zornoff LA, Inoue RM, Matsui M, et al. Myxedema ascites with elevated serum CA 125 concentration. Am J Med Sci. 2006;331(2):103–4.PubMedCrossRef Duarte DR, Chang CV, Minicucci MF, Zornoff LA, Inoue RM, Matsui M, et al. Myxedema ascites with elevated serum CA 125 concentration. Am J Med Sci. 2006;331(2):103–4.PubMedCrossRef
24.
Zurück zum Zitat Takahashi N, Shimada T, Ishibashi Y, Oyake N, Murakami Y. Transient elevation of serum tumor markers in a patient with hypothyroidism. Am J Med Sci. 2007;333(6):387–9.PubMedCrossRef Takahashi N, Shimada T, Ishibashi Y, Oyake N, Murakami Y. Transient elevation of serum tumor markers in a patient with hypothyroidism. Am J Med Sci. 2007;333(6):387–9.PubMedCrossRef
25.
Zurück zum Zitat Kawaguchi G, Abe E, Sasamoto R, Sasai K. Elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism after radiation therapy for cervical esophageal cancer. Int J clin oncol. 2010;15(1):104–8.PubMedCrossRef Kawaguchi G, Abe E, Sasamoto R, Sasai K. Elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism after radiation therapy for cervical esophageal cancer. Int J clin oncol. 2010;15(1):104–8.PubMedCrossRef
Metadaten
Titel
Transient elevation of serum carcinoembryonic antigen level in a patient with hypothyroidism
verfasst von
Heike Seifert
Sacha Rothschild
Publikationsdatum
01.12.2012
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2012
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-012-0056-6

Weitere Artikel der Ausgabe 4/2012

memo - Magazine of European Medical Oncology 4/2012 Zur Ausgabe